We can’t show the full text here under this license. Use the link below to read it at the source.
Glucagon-Like Peptide-1 Receptor Agonists and Peri-Procedural Aspiration Risk
Glucagon-Like Peptide-1 Receptor Agonists and the Risk of Aspiration Around Medical Procedures
AI simplified
Abstract
A combined risk ratio of 1.00 for elective surgery studies suggests no increased risk of aspiration/pneumonia associated with GLP-1 receptor agonist use.
- Three studies examining elective surgery found no increased aspiration/pneumonia risk linked to GLP-1 receptor agonists.
- Four studies focused on endoscopic procedures indicated a combined risk ratio of 1.10 for aspiration/pneumonia with GLP-1RA use.
- A separate analysis revealed opioid medications had a significantly higher risk ratio of 2.68 for aspiration/pneumonia.
- Retrospective cohort studies did not consistently show an association between GLP-1RA use and aspiration/pneumonia risk.
AI simplified
Key numbers
1.00
Combined for
from 3 studies examining outcomes.
1.10
Combined for
from 4 studies assessing outcomes.
2.68
Increased Risk with Opioids
comparing opioid users to nonusers in one study.